bioMerieux S.A. buy UBS Group AG
Start price
24.08.24
/
50%
€103.80
Target price
24.08.25
-
Performance (%)
22.64%
End price
25.08.25
€127.30
Summary
This prediction ended on 25.08.25 with a price of €127.30. The prediction had a final performance of 22.64%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| bioMerieux S.A. | 3.374% | 3.374% | -39.950% |
| iShares Core DAX® | -0,10 % | 0,54 % | 3,31 % |
| iShares Nasdaq 100 | 0,59 % | -2,39 % | 30,86 % |
| iShares Nikkei 225® | -0,05 % | -2,75 % | 60,15 % |
| iShares S&P 500 | 0,94 % | 1,29 % | 23,99 % |
Comments by UBS_Group_AG for this prediction
In the thread bioMerieux S.A. diskutieren
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for BMXMF provided by MarketBeat
In the thread Trading bioMerieux S.A.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten